申请人:ABIDE THERAPEUTICS, INC.
公开号:US20190202801A1
公开(公告)日:2019-07-04
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of pain.
本文提供了哌嗪氨基甲酸酯和包含该化合物的药物组合物。所述化合物和组合物可用作MAGL和/或ABHD6的调节剂。此外,所述化合物和组合物可用于治疗疼痛。